BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 1999
View Archived Issues
Role of pyruvate dehydrogenase in diabetes
Read More
News from ADA: antidiabetic efficacy of the ingredients of an animal prostate extract
Read More
New insulin preparation with improved stability for delivery via implanted pump
Read More
Retavase now available in Canada for emergency treatment of heart attacks
Read More
NN-304 is a safe and predictable insulin analogue in human studies
Read More
Draxis acquires Canadian rights to eight neurology products from Elan
Read More
Toll-like receptors implicated in septic shock
Read More
New product for anemia in hemodialysis patients now available in U.S.
Read More
Rebetol combination therapy for treatment of chronic HCV launched in Germany
Read More
New class of compounds for sickle cell disease and abnormal cell proliferation
Read More
AxyS claims heterocyclic factor Xa inhibitors
Read More
Antagonists of P2Y2 receptors designed at Astra (AstraZeneca)
Read More
New integrin receptor antagonists synthesized at DuPont
Read More
Schering-Plough scientists prepare thrombin receptor antagonists
Read More
Inhibitors of serine proteases in the pipeline at 3-D
Read More
EP-70905, a GHRP analogue with cardiovascular effects
Read More
Xenova refocuses research at MetaXen subsidiary
Read More
U.S.-Mexican team identifies FL-104, a potent and selective ERalpha ligand
Read More
DPP-IV inhibitor isoleucine thiazolidide is effective in rat model of type II diabetes
Read More
PRL-2915: a potent, subtype-selective SRIF antagonist from Biomeasure, Tulane
Read More
Nateglinide: an insulin secretagogue with significant advantages over other drugs in its class
Read More
Structure, synthesis and pharmacological activity of SIB-1553A presented by Sibia
Read More
Ziconotide use not associated with respiratory depression according to rat study
Read More
Phase III trial initiated for MRI contrast agent AngioMARK
Read More
ImmunoGen receives second milestone payment for anticancer prodrug from SmithKline Beecham
Read More
Results from first phase II trial of orally active PAF inhibitor in multiple sclerosis discouraging
Read More
Pharmacokinetic data for exendin-4 in rats presented at ENDO '99
Read More
Janssen withdraws antihistamine astemizole from the market
Read More
PRL-2903: a tool for the study of somatostatin receptors in diabetes
Read More
Anti-VEGF antibody reverses ascites associated with ovarian cancer in rodent model
Read More